Selected article for: "human human and MERS cov infection"

Title: MERS: Progress on the global response, remaining challenges and the way forward
  • Cord-id: d5l60cgc
  • Document date: 2018_9_17
  • ID: d5l60cgc
    Snippet: This article summarizes progress in research on Middle East Respiratory Syndrome (MERS) since a FAO-OIE-WHO Global Technical Meeting held at WHO Headquarters in Geneva on 25–27 September 2017. The meeting reviewed the latest scientific findings and identified and prioritized the global activities necessary to prevent, manage and control the disease. Critical needs for research and technical guidance identified during the meeting have been used to update the WHO R&D MERS-CoV Roadmap for diagnos
    Document: This article summarizes progress in research on Middle East Respiratory Syndrome (MERS) since a FAO-OIE-WHO Global Technical Meeting held at WHO Headquarters in Geneva on 25–27 September 2017. The meeting reviewed the latest scientific findings and identified and prioritized the global activities necessary to prevent, manage and control the disease. Critical needs for research and technical guidance identified during the meeting have been used to update the WHO R&D MERS-CoV Roadmap for diagnostics, therapeutics and vaccines and a broader public health research agenda. Since the 2017 meeting, progress has been made on several key actions in animal populations, at the animal/human interface and in human populations. This report also summarizes the latest scientific studies on MERS since 2017, including data from more than 50 research studies examining the presence of MERS-CoV infection in dromedary camels.

    Search related documents:
    Co phrase search for related documents
    • academic research and action plan: 1
    • academic research and address need: 1, 2
    • academic research and longitudinal study: 1
    • academic research and lopinavir ritonavir: 1
    • accelerated research and address need: 1, 2, 3
    • action plan and address need: 1
    • acute sari respiratory infection and longitudinal study: 1
    • address need and longitudinal study: 1, 2, 3
    • address need and lopinavir ritonavir: 1
    • long term protection and lopinavir ritonavir: 1, 2
    • longitudinal study and lopinavir ritonavir: 1